# T-Cypher Bio

Source: https://onco.cc/companies/t-cypher-bio/  
OnCo record `t-cypher-bio` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A small company near Oxford that designs medicines to point the immune system at new targets found only on diseased cells, for solid cancers and some autoimmune diseases.

## Summary

T-Cypher Bio states that it develops immune-engaging medicines against novel disease-specific targets for cancer and autoimmune disease, with a pipeline across a range of solid tumours and selected autoimmune diseases, built on proprietary platforms that combine laboratory and computational methods (T-Cypher Bio website). Its registered address is Barton House, the Quadrant, Abingdon (T-Cypher Bio website). Its team page says that a number of inventions from the University of Oxford laboratory of its scientific co-founder have been licensed to the company (T-Cypher Bio, About us).

## Fields

- Kind: Company
- Last checked: 2026-11-05
- Also known as: T-Cypher Bio Ltd; T-Cypher
- Tags: immune-engager
- HQ: Abingdon, Oxfordshire
- Type: biotech
- Website: https://www.tcypherbio.com

## Sources

- T-Cypher Bio website: https://www.tcypherbio.com/
- T-Cypher Bio, About us: https://www.tcypherbio.com/about-us/

## Connected records

- people: [Cassian Yee](https://onco.cc/people/cassian-yee/)

---
JSON: https://onco.cc/api/v1/entities/t-cypher-bio.json